MAY 30, 2019 6:00 AM PDT

Improved Cancer Tracking Through Precision Quantification of Circulating Nucleic Acid Biomarkers

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Chief Scientific Officer, COMBiNATi
    Biography
      Megan Dueck earned her Master of Science degree from UC San Diego in Molecular Pathology in 2005 and completed her PhD in Biological Sciences at UC San Diego in August 2016. From 2005 until 2011, she was a lecturer in the UC Berkeley Bioengineering department receiving awards and NSF funding to develop undergrad curriculum interfacing molecular biology with microfluidics. Megan has over 15 years of experience with microfluidic device and assay design. Currently Megan is a co-founder and CSO for an SF Bay Area biotech hardware company working to bring a revolutionary digital PCR platform to market.

    Abstract

    Oncologists have many options when tasked with treating a patient’s cancer. Unfortunately, many cancer drugs and therapies come with potentially debilitating side effects. As such, it is essential that a doctor track a patient’s response to therapy and change course as early as possible if the therapy is not effective at eradicating cancer cells.  Precision, personalized tracking of cancer burden is also critical for monitoring patients in remission so that therapy can be restarted the moment the cancer resurfaces.  Digital PCR offers clinicians the necessary tool for absolute quantification and precision tracking of circulating DNA cancer biomarkers. COMBiNATi has developed a novel digital PCR platform consisting of a micro-molded plastic consumable and fully integrated instrument designed to address the specific needs of a routine clinical diagnostic tool.  Using a patient-specific assay we have proven the platform’s ability to precisely track a specific cancer patient’s response to therapy and ultimate transition to complete molecular remission. 

    Learning Objectives: 

    1. What is meant by "liquid biopsy", "precision cancer monitoring" and "personalized medicine"?  
    2. What is digital PCR and how can it be used to track a patient's response to therapy or recurrence?
     


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    MAR 18, 2021 8:00 AM PDT
    C.E. CREDITS
    MAR 18, 2021 8:00 AM PDT
    DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    MAY 18, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    MAY 18, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 18, 2021 Time: 7:00am PDT, 10:00am EDT Proteins encoded by mutant genes in cancers can be processed and presented on tumor cell surface by human leukocyte antigen (HLA) molecules,...
    MAY 30, 2019 6:00 AM PDT

    Improved Cancer Tracking Through Precision Quantification of Circulating Nucleic Acid Biomarkers

    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Immunology

    Clinical Diagnostics

    Cancer Diagnostics

    Molecular Biology

    Biomarkers

    Laboratory Testing

    Pcr/rt-Pcr/real-Time Pcr

    Cancer Research

    Dna

    Genetics

    Microbiology

    Antibodies

    Research And Development

    Chemistry

    Gene Sequencing

    Geography

    North America67%

    Asia25%

    Europe8%

    Registration Source

    Website Visitors100%

    Job Title

    Medical Laboratory Technician36%

    Student18%

    Clinical Laboratory Scientist9%

    Executive9%

    Educator/Faculty9%

    Scientist9%

    Lab Management9%

    Organization

    Academic Institution33%

    Clinical Laboratory17%

    Hospital17%

    Consultant8%

    General Laboratory8%

    Manufacturer - Other8%

    Biotech Company8%


    Show Resources
    Loading Comments...
    Show Resources